Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,412 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Network and pairwise meta-analysis of the effects of novel hypoglycemic agents on cardiorenal outcomes in patients with type 2 diabetes and heart failure.
Ye X, Wu Q, Li L, Huang M, Wang S. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- GLP-1-based therapies for reduction of heart failure and cardiovascular outcomes: A systematic review and meta-analysis of randomized controlled trials.
Sajid EU, Ali T, Azeem B, Hassan D, Waqar M, Rayyan Ahmed S, Ahmed Meenai E, A Abu Elainein M, Soomro I, Hasnain Azeem M, Ramalingam A, Bawa D, Baig M, Fakih N, J Saldanha I. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Dose-response and time-course effects of ecnoglutide in type 2 diabetes: a systematic review and meta-analysis of efficacy.
Feng Y, Sun C, Li X, Hu L, Zhou K, Li L, Yuan Y, Yu L, Wu M, Liu L. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Combined use of SGLT2 inhibitor and GLP-1 receptor agonist versus either monotherapy for cardiorenal Outcomes: an exploratory network meta-analysis of 16 randomized trials.
Banerjee M, Basu M, Mukhopadhyay P, Ghosh S. · Endocrine · 2026 · cited 0 timessystematic review, network meta-analysis
- Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis.
Qi H, Gao Q, Chen H, Du X, Pan B. · PeerJ · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Effects of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Kanbay M, Shah E, AlShiab R, Ozbek L, Ay S, Rustamov A, Covic A, Mallamaci F, Zoccali C. · Diabetes Obes Metab · 2026 · cited 5 timesmeta-analysis, systematic review
- GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Across Myocardial Infarction-Defined Populations: A Systematic Review and Meta-Analysis.
Batista PG, Dos Santos Silva RRA, Montenegro MV, Malik M, Dandamudi M, de Oliveira JP, Molinari ME, de Lucena LA, Huntermann R, Giorgi J, Bacca COF. · Am J Cardiovasc Drugs · 2026 · cited 0 timesmeta-analysis, systematic review
- Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis.
Yang Q, Hassan W, Ahmed H, Zheng H. · BMC Ophthalmol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Exploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis.
Alper A, Fagin A, Karthikeyan A, Karp A, Terashima R, Murli H, Gershon A, Faillace R. · High Blood Press Cardiovasc Prev · 2026 · cited 1 timesmeta-analysis, systematic review
- Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis.
Alfawaz M, Bajamaan D, Alghamdi L, Alorfi Y, Khared S, Ameen N, Alamri R, Abuladel M, Alshehri R, Altowairqi S. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Combination Therapy of GLP-1 RA and SGLT2i in Patients with Established Heart Failure: A Systematic Review and Meta-Analysis of Observational Studies.
Tristan CD, Irnizarifka I, Kynaya EM, Gani M, Wijayanto MA, Asrial AA, Pranata R. · Am J Cardiovasc Drugs · 2026 · cited 0 timesmeta-analysis, systematic review
- Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis.
Chuang MH, Ho CW, Wang HY, Pan HC, Wu VC, Tu YK, Chen JY. · CMAJ · 2026 · cited 0 timesOpen accesssystematic review, network meta-analysis
- Efficacy and safety of orforglipron 12 mg versus orforglipron 36 mg maintenance dose among patients with obesity with or without diabetes: a systematic review and comprehensive meta-analysis.
Hegaz MG, Aboud MYA, Kamel AII, Naveed MA, Elsayed OG, Sorathia AZ. · BMC Endocr Disord · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis.
Pisani D, Lorenza D, Fordellone M, Cerillo A, Fatigati M, Hanulíková P, Mariniello A, De Franciscis P, Pasquini L, La Verde M. · Endocrine · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes.
Andronescu AC, Ciumărnean L, Orășan OH, Cozma A, Leah NV, Lucaciu RL, Hangan AC, Procopciuc LM. · Int J Mol Sci · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Cardiovascular outcomes of SGLT2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes and a history of myocardial infarction: a systematic review and network meta-analysis of randomized controlled trials.
Ren Y, Yang H, Zhang S, Hu T, Tan Q, Wang J, Xu Y. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accesscomparative study, systematic review
- Effects of Multicomponent Training on Body Composition and Cardiorespiratory Fitness in Adults With Type 2 Diabetes: A Randomized Controlled Trial.
Skoradal MB, Kristiansen J, Póvoas S, Johannesen HL, Ellingsgaard H, Olsen HW, Mohr M, Sjúrðarson T. · Scand J Med Sci Sports · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis.
Li L, Shui D, Zhang X, Tan B, Deng Y. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Effects of intensive insulin therapy combined with non-insulin antihyperglycemic agents on glycemic control, variability, and metabolic outcomes in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Shen Z, Li J, Zhao Z, Chen Z, Ma X, Zhou J, Jiao L, Wang J. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients
Ali M, Mohammed O, Suhail A, Naseer F, Shafi N, Arshad M, Shazly O, Mohmand M, Ahmad H, Binashikhbubkr N, Maaz M, Khan M, Neppala S, Al-Jarshawi M, Hemida M. · Front Cardiovasc Med · cited 0 timesOpen accesssystematic-review, review
- Efficacy of SGLT2 inhibitors, GLP-1 receptor agonists, and aerobic exercise for moderate-to-severe obstructive sleep apnea in overweight or obese patients: a network meta-analysis.
Zheng J, Zhu Z, Bao Y, Hu Y, Dong Z, Zhao A, Li Q, Wang Y, Zhu M, Chen P. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials.
Mansouri ES, Queiroga F, Barbosa LM, Azevedo AK, Donaldy W, Mirbolouk MJ, Blair CV, Rivera A, Ferreira Felix I, Abreu M, Deshmukh AJ, DeSimone CV. · J Am Heart Assoc · 2026 · cited 1 timesOpen accessmeta-analysis, research support, non-u.s. gov't
- GLP-1-based therapies and limb outcomes in PAD: a systematic review and meta-analysis of real-world studies.
Boccatonda A, D'Ardes D, Brighenti A, Cipollone A, Simeone PG, Guagnano MT, Serra C, Santilli F, Cipollone F. · Diabetes Res Clin Pract · 2026 · cited 0 timesmeta-analysis, systematic review
- Impact of GLP-1 Receptor Agonists on Cognitive Performance in Adults at Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Abbatecola AM, Migliara G, D'Agostino F, Veronese N, Giuliani A, Caponnetto S, Corbi G, Signoriello E, Incalzi RA, Paolisso G. · Nutrients · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Effect of glucagon-like peptide-1 receptor agonists on body weight and urinary albumin-to-creatinine ratio in patients with and without type 2 diabetes: A systematic review and meta-analysis.
Huang R, Wang B. · J Int Med Res · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.